Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 69238-2675

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 69238-2675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 1)

A line graph comparing the systolic blood pressure (SBP) less than 140 mmHg rates over baseline SBP values (mmHg) for different treatments: Placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10/40 mg. The graph illustrates the relative effectiveness of these treatments in lowering SBP.*

FDA Label Image

10-40 Label (Amlodipine And Olmesartan Medoxomil Tablets 10)

Label for Amlodipine and Olmesartan Medoxomil Tablets USP with strength 10 mg/40 mg. The label includes storage instructions, manufacturer information (ScieGen Pharmaceuticals, Inc.), batch (LOT) and expiration (EXP) fields, a barcode, and the NDC 69238-2674-1. The container holds 1000 tablets for prescription use.*

FDA Label Image

Figures 1 & 2 (Amlodipine And Olmesartan Medoxomil Tablets 2)

A line graph depicting the relationship between baseline diastolic blood pressure (DBP) in mmHg on the x-axis and the percentage of DBP measurements under 90 mmHg on the y-axis. The graph compares four treatments: placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and the combination of Amlodipine and Olmesartan Medoxomil 10/40 mg tablets. Each treatment is shown with distinct markers and lines to illustrate their effects across baseline DBP values.*

FDA Label Image

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 3)

A line graph showing the proportion of patients with systolic blood pressure (SBP) less than 130 mmHg relative to baseline SBP (mmHg). The chart compares placebo, OL40 mg, AML10 mg, and amlodipine and olmesartan medoxomil tablets 10/40 mg treatments, with each treatment represented by distinct markers and lines.*

FDA Label Image

Figures 3 & 4 (Amlodipine And Olmesartan Medoxomil Tablets 4)

A line graph comparing the percentage of patients with diastolic blood pressure (DBP) less than 80 mmHg against baseline DBP values in mmHg. The graph includes data for placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and amlodipine and olmesartan medoxomil tablets 10/40 mg. Each treatment group is represented by distinct markers connected by lines.*

FDA Label Image

Amlodipine Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 5)

Chemical structure diagrams of the active ingredients Amlodipine and Olmesartan Medoxomil shown as molecular structures with labeled atoms. These illustrations represent the chemical composition of the components in the combination tablet.*

FDA Label Image

Olmesartan Chemical Structure (Amlodipine And Olmesartan Medoxomil Tablets 6)

Chemical structure diagram of Amlodipine and Olmesartan Medoxomil showing the molecular arrangement of the active ingredients in the film-coated tablet formulation by Amneal Pharmaceuticals NY LLC.*

FDA Label Image

5-20 Label (Amlodipine And Olmesartan Medoxomil Tablets 7)

Label for Amlodipine and Olmesartan Medoxomil tablets, USP, 5 mg/20 mg strength. The label indicates each tablet contains 5 mg amlodipine and 20 mg olmesartan medoxomil. The package contains 1000 film-coated oral tablets and displays the NDC 69238-2675-1. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

10-20 Label (Amlodipine And Olmesartan Medoxomil Tablets 8)

Label for Amlodipine and Olmesartan Medoxomil Tablets USP 10 mg/20 mg by ScieGen Pharmaceuticals, showing tablet composition of 10 mg amlodipine and 20 mg olmesartan medoxomil. The label includes storage instructions, NDC 69238-2673-1, package size of 1000 tablets, barcode, and manufacturer information.*

FDA Label Image

5-40 Label (Amlodipine And Olmesartan Medoxomil Tablets 9)

Label for Amlodipine and Olmesartan Medoxomil tablets, USP, 5 mg/40 mg strength, manufactured by ScieGen Pharmaceuticals Inc. The label shows the NDC 69238-2676-1 and indicates each tablet contains 5 mg amlodipine and 40 mg olmesartan medoxomil. The package contains 1000 tablets with storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.